• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

Comprehensive Overview of 2-Pyridinamine, 6-cyclopropyl-4-methyl- (CAS No. 234110-18-0): Properties, Applications, and Research Insights

The compound 2-Pyridinamine, 6-cyclopropyl-4-methyl- (CAS No. 234110-18-0) is a specialized organic molecule that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural features. This pyridine derivative is characterized by a cyclopropyl substitution at the 6-position and a methyl group at the 4-position, which contribute to its distinct chemical reactivity and potential biological activity. Researchers are increasingly exploring its role as a building block in drug discovery, particularly in the development of small-molecule inhibitors targeting enzymes or receptors involved in disease pathways.

In recent years, the demand for heterocyclic compounds like 2-Pyridinamine, 6-cyclopropyl-4-methyl- has surged, driven by their versatility in medicinal chemistry and material science. A trending topic in scientific forums revolves around its potential as a scaffold for kinase inhibitors, a class of therapeutics widely investigated for cancer and inflammatory diseases. Computational studies (in silico modeling) suggest that the cyclopropyl group may enhance binding affinity to protein targets, making this compound a focal point for structure-activity relationship (SAR) studies.

From a synthetic perspective, CAS No. 234110-18-0 is often synthesized via Pd-catalyzed cross-coupling reactions or nucleophilic aromatic substitution, methods frequently searched by chemists optimizing laboratory protocols. Its physicochemical properties—such as moderate lipophilicity (LogP) and hydrogen-bonding capacity—make it suitable for bioavailability optimization in drug candidates. Notably, its stability under physiological conditions is a recurring subject in ADME (Absorption, Distribution, Metabolism, Excretion) research.

Beyond pharmaceuticals, 6-cyclopropyl-4-methyl-2-pyridinamine has emerging applications in agrochemical formulations. Its structural motifs align with trends in green chemistry, where researchers seek eco-friendly alternatives to traditional pesticides. Patent analyses reveal its incorporation into herbicidal and fungicidal agents, addressing global concerns about sustainable crop protection—a hot topic in precision agriculture discussions.

Analytical characterization of this compound typically involves HPLC purification, NMR spectroscopy, and mass spectrometry, techniques commonly queried in academic and industrial settings. Recent publications highlight its detection via LC-MS/MS in metabolic studies, reflecting broader interests in biomarker discovery and toxicological screening. Regulatory databases classify it as a research chemical, emphasizing its non-clinical status but high utility in exploratory studies.

In conclusion, 2-Pyridinamine, 6-cyclopropyl-4-methyl- (CAS No. 234110-18-0) represents a compelling case study in modern molecular design. Its intersection with drug development, sustainable chemistry, and analytical innovation positions it as a valuable entity for interdisciplinary research. As AI-driven virtual screening accelerates compound prioritization, this pyridine derivative’s relevance is poised to grow—answering frequent search queries about “next-generation heterocycles” and “targeted therapeutic scaffolds.”

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)